Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Pabst

Showing results (21-30 of 332) with videos related to

Pageof 34
Sort By:
Journal of Contaminant Hydrology|September 12, 2024
Effect of waste rock particle size on acid mine drainage generation: Practical implications for reactive transport modelingJunghyun Lim, Karine Sylvain, Thomas Pabst, et al.
Current Issues in Molecular Biology|April 26, 2024
FLT3 and IRAK4 Inhibitor Emavusertib in Combination with BH3-Mimetics in the Treatment of Acute Myeloid LeukemiaKatja Seipel, Harpreet Mandhair, Ulrike Bacher, et al.
Current Issues in Molecular Biology|September 27, 2023
HSP90 Inhibitor PU-H71 in Combination with BH3-Mimetics in the Treatment of Acute Myeloid LeukemiaKatja Seipel, Scarlett Kohler, Ulrike Bacher, et al.
Methods in Enzymology|January 27, 2011
Activation of the unfolded protein response in human acute myeloid leukemiaJulian A Schardt, Beatrice U Mueller, Thomas Pabst
Infectious Diseases (London, England)|July 9, 2016
Low impact of urine cultures as a diagnostic tool in patients with neutropenic feverJulia Steinrücken, Thomas Pabst, Stefan Zimmerli, et al.
Cancers|February 5, 2021
BMI1-Inhibitor PTC596 in Combination with MCL1 Inhibitor S63845 or MEK Inhibitor Trametinib in the Treatment of Acute LeukemiaKatja Seipel, Basil Kopp, Ulrike Bacher, et al.
Swiss Medical Weekly|February 21, 2014
A single-centre cohort of patients with systemic light chain AL-amyloidosis treated with conventional chemotherapy or with high-dose chemotherapy and autologous stem cell transplantationJoëlle Raschle, Yara Banz, Thomas Suter, et al.
Biochimica Et Biophysica Acta|July 12, 2015
Functional interplay of SP family members and nuclear factor Y is essential for transcriptional activation of the human Calreticulin geneJulian A Schardt, Manuela Keller, Katja Seipel, et al.
Blood|August 24, 2012
The angiogenesis inhibitor vasostatin is regulated by neutrophil elastase-dependent cleavage of calreticulin in AML patientsSarah Mans, Yara Banz, Beatrice U Mueller, et al.
Cancers|September 22, 2018
Autologous Transplantation for Older Adults with AMLBeatrice U Mueller, Katja Seipel, Ulrike Bacher, et al.
Pageof 34

Showing results (21-30 of 332) with videos related to

Sort By:
Pageof 34
Journal of Contaminant Hydrology|September 12, 2024
Effect of waste rock particle size on acid mine drainage generation: Practical implications for reactive transport modelingJunghyun Lim, Karine Sylvain, Thomas Pabst, et al.
Current Issues in Molecular Biology|April 26, 2024
FLT3 and IRAK4 Inhibitor Emavusertib in Combination with BH3-Mimetics in the Treatment of Acute Myeloid LeukemiaKatja Seipel, Harpreet Mandhair, Ulrike Bacher, et al.
Current Issues in Molecular Biology|September 27, 2023
HSP90 Inhibitor PU-H71 in Combination with BH3-Mimetics in the Treatment of Acute Myeloid LeukemiaKatja Seipel, Scarlett Kohler, Ulrike Bacher, et al.
Methods in Enzymology|January 27, 2011
Activation of the unfolded protein response in human acute myeloid leukemiaJulian A Schardt, Beatrice U Mueller, Thomas Pabst
Infectious Diseases (London, England)|July 9, 2016
Low impact of urine cultures as a diagnostic tool in patients with neutropenic feverJulia Steinrücken, Thomas Pabst, Stefan Zimmerli, et al.
Cancers|February 5, 2021
BMI1-Inhibitor PTC596 in Combination with MCL1 Inhibitor S63845 or MEK Inhibitor Trametinib in the Treatment of Acute LeukemiaKatja Seipel, Basil Kopp, Ulrike Bacher, et al.
Swiss Medical Weekly|February 21, 2014
A single-centre cohort of patients with systemic light chain AL-amyloidosis treated with conventional chemotherapy or with high-dose chemotherapy and autologous stem cell transplantationJoëlle Raschle, Yara Banz, Thomas Suter, et al.
Biochimica Et Biophysica Acta|July 12, 2015
Functional interplay of SP family members and nuclear factor Y is essential for transcriptional activation of the human Calreticulin geneJulian A Schardt, Manuela Keller, Katja Seipel, et al.
Blood|August 24, 2012
The angiogenesis inhibitor vasostatin is regulated by neutrophil elastase-dependent cleavage of calreticulin in AML patientsSarah Mans, Yara Banz, Beatrice U Mueller, et al.
Cancers|September 22, 2018
Autologous Transplantation for Older Adults with AMLBeatrice U Mueller, Katja Seipel, Ulrike Bacher, et al.
Pageof 34